Kimberly Bowron Sells Shares of GEVO

Kimberly Bowron, the Chief of Staff at GEVO, sold 15,470 shares of the company on June 12, 2026. The shares were sold at an average price of $1.43 each, bringing the total value of the transaction to about $22,122. This sale was conducted as part of a pre-planned trading arrangement.

Other Institutional Activity in GEVO

Several institutional investors have recently adjusted their stakes in GEVO. BlackRock, Inc. trimmed its holdings by 49,779 shares, leaving it with 17,321,015 shares valued at approximately $47.3 million. Vanguard Capital Management LLC acquired 10,133,640 shares, now holding the same amount, with a value of about $27.7 million. State Street Corp increased its position by 641,544 shares, reaching a total of 9,065,919 shares worth $24.7 million. Geode Capital Management, LLC added 219,461 shares to hold 5,881,507 shares, valued at $16.1 million, while Goldman Sachs Group Inc significantly boosted its stake by 1,018,941 shares, ending with 3,878,382 shares valued at $10.6 million.

Gevo, Inc. Stock Down 14.4%

Shares of GEVO were trading at $1.43. The stock has seen varying levels of activity from institutional investors, reflecting ongoing interest in the company's performance and potential. The broader market conditions and company-specific factors continue to influence GEVO's stock price.

Insider Buying and Selling at Gevo, Inc.

In addition to Kimberly Bowron, several other insiders executed planned sales on June 12, 2026. Andrew Shafer, Chief Marketing, Customer & Brand Officer, sold 9,443 shares at $1.43 each. CFO Oluwagbemileke Yusuf sold 63,028 shares at $1.40 per share. VP of Accounting and Treasurer, Gendenjamts Davaajargal, sold 4,293 shares at $1.43. President & COO Christopher Michael Ryan sold 35,196 shares at $1.43, while CEO Paul Bloom sold 35,189 shares at the same price. Patrick Gruber sold 157,563 shares at $1.40.

Analysts Set New Price Targets

Analysts have maintained their ratings on GEVO. On May 22, 2026, UBS maintained a 'hold' rating with a price target of $2.00. Earlier, on April 16, 2026, Northland Capital Markets reiterated a 'buy' rating with a target of $3.50. The consensus among analysts is cautiously optimistic, with a mix of 'hold' and 'buy' ratings.

Bottom Line

Kimberly Bowron's recent sale of GEVO shares was part of a planned transaction, reflecting her current position and strategy. Investors and analysts continue to watch GEVO closely, with institutional investors adjusting their stakes and multiple analysts maintaining their ratings. As always, these transactions and ratings offer insights into the company's current standing but are not necessarily indicators of future performance.